Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$1.59 USD
-0.06 (-3.64%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.60 +0.01 (0.63%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Actinium Pharmaceuticals, Inc. has a market cap of $51.47M, which represents its share price of $1.65 multiplied by its outstanding shares number of 31.20M. As a small-cap company, ATNM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ATNM 1.59 -0.06(-3.64%)
Will ATNM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ATNM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATNM
Is Armata Pharmaceuticals (ARMP) Stock Outpacing Its Medical Peers This Year?
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?
ATNM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
All You Need to Know About Actinium (ATNM) Rating Upgrade to Strong Buy
Other News for ATNM
Is ATNM likely to continue lower? 50 Day Moving Average Resistance shows up after dropping 3.64%
Is ATNM setting up for a drop? 20 Day Moving Average Resistance shows up after gaining 2.48%
ATNM Fell Below 50 Day Moving Average on September 17
ATNM Crossed Above 50 Day Moving Average on September 16
Is ATNM set to breakout? NR7 shows up after dropping 0.61%